Ayr Wellness Inc. (AYRWF)
(Delayed Data from OTC)
$1.89 USD
+0.07 (3.85%)
Updated Oct 14, 2024 03:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Income Statements
Fiscal Year end for Ayr Wellness Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 464 | 466 | 358 | 155 | 75 |
Cost Of Goods | 261 | 275 | 220 | 52 | 49 |
Gross Profit | 202 | 190 | 138 | 103 | 26 |
Selling & Adminstrative & Depr. & Amort Expenses | 240 | 433 | 194 | 87 | 64 |
Income After Depreciation & Amortization | -37 | -243 | -56 | 16 | -37 |
Non-Operating Income | 31 | 63 | 85 | -164 | -119 |
Interest Expense | 39 | 31 | 17 | 4 | 3 |
Pretax Income | -46 | -210 | 12 | -152 | -159 |
Income Taxes | 47 | 45 | 29 | 24 | 5 |
Minority Interest | -7 | -10 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -93 | -255 | -17 | -176 | -164 |
Extras & Discontinued Operations | -186 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -272 | -245 | -17 | -176 | -164 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 53 | -151 | 4 | 35 | -27 |
Depreciation & Amortization (Cash Flow) | 90 | 92 | 60 | 19 | 10 |
Income After Depreciation & Amortization | -37 | -243 | -56 | 16 | -37 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 74.10 | 68.64 | 57.33 | 27.89 | NA |
Diluted EPS Before Non-Recurring Items | -1.16 | -1.42 | -0.92 | -0.44 | NA |
Diluted Net EPS (GAAP) | -3.68 | -3.58 | -0.30 | -6.32 | NA |
Fiscal Year end for Ayr Wellness Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 117.31 | 118.04 | 114.84 | 114.39 |
Cost Of Goods | NA | 70.15 | 67.38 | 65.45 | 66.26 |
Gross Profit | NA | 47.16 | 50.66 | 49.38 | 48.13 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 54.83 | 52.63 | 58.92 | 49.58 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -7.67 | -1.97 | -9.54 | -1.45 |
Non-Operating Income | NA | 3.52 | -77.27 | -0.40 | 6.50 |
Interest Expense | NA | 20.33 | 17.62 | 10.57 | 10.77 |
Pretax Income | NA | -24.48 | -96.85 | -20.51 | -5.73 |
Income Taxes | NA | 14.83 | 11.48 | 9.78 | 13.54 |
Minority Interest | NA | -0.55 | 0.00 | -2.31 | -1.02 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -39.31 | -108.34 | -30.29 | -19.27 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | -0.67 | -1.00 |
Net Income (GAAP) | NA | -38.76 | -108.34 | -28.65 | -19.25 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 114.14 | 97.88 | 76.95 | 76.56 |
Diluted EPS Before Non-Recurring Items | NA | -0.34 | -0.27 | -0.36 | -0.24 |
Diluted Net EPS (GAAP) | NA | -0.34 | -1.08 | -0.24 | -0.25 |